William Pate
CIK 1180447 · Director · last filed 2026-10-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PARR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PARR | Director | 451,921 | $83.42 | $37.70M | -$17.09M | 62 | 2026-10-06 |
| COVANTA HOLDING CORP (CVA) Delisted | Director | 407,177 | $20.26 | $8.25M | -$233.1K | 11 | 2015-05-08 |
| Archrock, Inc. (EXH) Delisted | Director | 42,640 | — | — | $0 | 20 | 2013-01-02 |
| MiddleBrook Pharmaceuticals, Inc. (MBRK) Delisted | Director | — | — | — | $0 | 2 | 2009-06-24 |
| HANOVER COMPRESSOR CO / (HC) Delisted | Director | 0 | — | — | $0 | 2 | 2007-08-20 |
| Adams Respiratory Therapeutics, Inc. (ARXT) Delisted | Director | 49,357 | — | — | -$367.8K | 6 | 2007-04-18 |
Recent Filings · Page 10 of 11
108 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-01-05 | Archrock, Inc. (EXH) Delisted | Grant (A) | +1,009 | $21.5K | EDGAR |
| 2008-10-02 | Archrock, Inc. (EXH) Delisted | Grant (A) | +531 | $17.0K | EDGAR |
| 2008-09-09 | MiddleBrook Pharmaceuticals, Inc. (MBRK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-07-02 | Archrock, Inc. (EXH) Delisted | Grant (A) | +230 | $16.4K | EDGAR |
| 2008-05-08 | Archrock, Inc. (EXH) Delisted | Grant (A) | +2,183 | $0 | EDGAR |
| 2008-05-02 | COVANTA HOLDING CORP (CVA) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2008-04-02 | Archrock, Inc. (EXH) Delisted | Grant (A) | +302 | $19.5K | EDGAR |
| 2008-01-25 | Archrock, Inc. (EXH) Delisted | Grant (A) | +183 | $15.0K | EDGAR |
| 2007-08-22 | Archrock, Inc. (EXH) Delisted | Grant (A) | +1,527 | $0 | EDGAR |
| 2007-08-20 | HANOVER COMPRESSOR CO / (HC) Delisted | Disp (D) | −4,700 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.